Get Live Data

PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight

Thu, 16th Jan 2020 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

BARCLAYS CUTS GLAXOSMITHKLINE TO 'UNDERWEIGHT' (EQUAL WEIGHT) - PRICE TARGET 1650 PENCE

----------

CREDIT SUISSE RAISES GLAXOSMITHKLINE PRICE TARGET TO 1860 (1800) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 8500 (8300) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 8500 (8200) PENCE - 'OUTPERFORM'

----------

JEFFERIES CUTS DIAGEO TO 'HOLD' (BUY) - PRICE TARGET 3600 PENCE

----------

JPMORGAN RAISES SEGRO PRICE TARGET TO 855 (775) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES INFORMA PRICE TARGET TO 873 (869) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BRITISH LAND CO PRICE TARGET TO 630 (605) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PEARSON PRICE TARGET TO 860 (950) PENCE - 'OVERWEIGHT'

----------

UBS RAISES WPP PRICE TARGET TO 1175 (1125) PENCE - 'BUY'

----------

GOLDMAN REINITIATES VODAFONE WITH 'BUY' - PRICE TARGET 190 PENCE

----------

CREDIT SUISSE CUTS GLENCORE PRICE TARGET TO 300 (310) PENCE - 'OUTPERFORM'

----------

JPMORGAN RAISES BAE SYSTEMS PRICE TARGET TO 715 (700) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES MEGGITT PRICE TARGET TO 730 (685) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

JPMORGAN CUTS UNITE GROUP TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 1200 PENCE

----------

JPMORGAN CUTS BIG YELLOW TO 'UNDERWEIGHT' (NEUTRAL) - TARGET 1150 (1050) PENCE

----------

JPMORGAN RAISES WORKSPACE GROUP TARGET TO 1220 (1160) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ST. MODWEN PROPERTIES TARGET TO 530 (490) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES HAMMERSON PRICE TARGET TO 300 (290) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES GREAT PORTLAND PRICE TARGET TO 880 (845) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES GRAINGER PRICE TARGET TO 330 (310) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES DERWENT LONDON TARGET TO 3720 (3500) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES ASSURA GROUP PRICE TARGET TO 81 (79) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ELECTROCOMPONENTS TO 'OVERWEIGHT' (NEUTRAL) - TARGET 774 (651) PENCE

----------

BARCLAYS CUTS SPIRENT TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 190 (159) PENCE

----------

JPMORGAN RAISES ULTRA ELECTRONICS PRICE TARGET TO 2400 (2200) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES QINETIQ PRICE TARGET TO 360 (340) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES DIPLOMA PRICE TARGET TO 1760 (1730) PENCE - 'NEUTRAL'

----------

JPMORGAN INITIATES PPHE HOTELS WITH 'OVERWEIGHT' - TARGET 2500 PENCE

----------

UBS RAISES ASHMORE GROUP PRICE TARGET TO 527 (480) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE RAISES ASHMORE GROUP PT TO 480 (440) PENCE - 'UNDERPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN CUTS INTU PROPERTIES PRICE TARGET TO 25 (29) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES HELICAL PRICE TARGET TO 475 (450) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES GAMMA COMMUNICATIONS PRICE TARGET TO 1350 (1250) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS IQE TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 55 (73) PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
8910111213141516

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.